
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY | 
| 49 | 1584.90 | 1609.00 | 1 | 
| 124 | 1583.45 | 1610.00 | 25 | 
| 82 | 1583.30 | 1620.00 | 2 | 
| 1 | 1580.95 | 1625.00 | 25 | 
| 2 | 1580.10 | 1638.00 | 54 | 
| 0 | Total | Total | 0 | 
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY | 
| 49 | 1584.90 | 1609.00 | 1 | 
| 124 | 1583.45 | 1610.00 | 25 | 
| 82 | 1583.30 | 1620.00 | 2 | 
| 1 | 1580.95 | 1625.00 | 25 | 
| 2 | 1580.10 | 1638.00 | 54 | 
| 0 | Total | Total | 0 | 
| Open | 1,605.00 | 
| Previous Close | 1,597.30 | 
| Volume | 43,178.00 | 
| Value (Lacs) | 691.28 | 
| VWAP | 1,598.30 | 
| Beta | |
| Mkt Cap (Rs. Cr.) | 21,808 | 
| High | 1,612.00 | 
| Low | 1,585.20 | 
| UC Limit | 1,916.70 | 
| LC Limit | 1,277.90 | 
| 52 Week High | 1,910.00 | 
| 52 Week Low | 1,097.20 | 
| Face Value | 1.00 | 
| All Time High | 1,910.00 | 
| All Time Low | 321.00 | 
| 20D Avg Volume | 273,978 | 
| 20D Avg Delivery(%) | 25.80 | 
| Book Value Per Share | 203.47 | 
| Dividend Yield | 0.46 | 
| TTM EPS See historical trend | 28.41 (+10.96% YoY) | 
| TTM PE See historical trend | 56.35 (Average PE) | 
| P/B See historical trend | 7.87 (High P/B) | 
| Sector PE | 40.00 | 
*Delayed by 20 seconds.
Stock Score
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 | 
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - | 
| Fibonacci | - - | - - | - - | - - | - - | - - | - - | 
| Camarilla | - - | - - | - - | - - | - - | - - | - - | 
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - -  | 
                      S1 | - - | 
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - | 
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - | 
| 10 | - - | 
| 20 | - - | 
| 50 | - - | 
| 100 | - - | 
| 200 | - - | 
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 | 
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - | 
| Fibonacci | - - | - - | - - | - - | - - | - - | - - | 
| Camarilla | - - | - - | - - | - - | - - | - - | - - | 
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - -  | 
                      S1 | - - | 
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - | 
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days | 
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 | 
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - | 
| Fibonacci | - - | - - | - - | - - | - - | - - | - - | 
| Camarilla | - - | - - | - - | - - | - - | - - | - - | 
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - -  | 
                      S1 | - - | 
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - | 
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days | 
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% | 
6 out of 9 years Eris Lifesciences has given positive returns in November.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) | 
|---|---|---|---|---|---|
| November | 37.44% (2017) | 11.02% | -12.35% (2021) | -9.90% | 4.04% | 
                                
                            
                                    
                                Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y Aug 12 2025 01:06 PM
                                    
                                Eris Lifesciences to meet investors in Singapore and Hong Kong Aug 11 2025 05:27 PM
                                    
                                Neutral Eris Lifesciences; target of Rs 1700: Motilal Oswal Aug 08 2025 01:03 PM
                                    
                                Eris Lifesciences eyes Novo Nordisku2019s exit to expand human insulin play in India Aug 07 2025 09:31 PM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 2079000 | Price 1350.18 | % Traded 1.55 | 
| Qty 2000000 | Price 1350 | % Traded 1.49 | 
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda | 
|---|
| Ex-Date | Type | Dividend (Rs) | 
|---|
| Announcement Date | Ex-Bonus | Ratio | 
|---|
| Ex-Split | Old FV | New FV | 
|---|
| Ex-Right | Ratio | Premium | 
|---|
| Date | Agenda | 
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity | 
|---|---|---|---|---|---|---|---|---|---|---|
| Eris Life | 1,601.00 | 0.23 | 21,807.79 | 56.35 | 7.87 | 12.32 | 21.51 | 374 | 2,893 | 0.85 | 
| Sun Pharma | 1,690.00 | -0.96 | 405,487.61 | 39.09 | 5.61 | 15.13 | -6.57 | 10,980 | 52,578 | 0.03 | 
| Divis Labs | 6,804.50 | 0.01 | 180,638.10 | 78.33 | 12.07 | 14.63 | 15.30 | 2,191 | 9,360 | 0.00 | 
| Cipla | 1,503.30 | -0.54 | 121,432.25 | 22.32 | 3.89 | 16.90 | -5.13 | 5,291 | 27,547 | 0.00 | 
| Torrent Pharma | 3,575.00 | -1.47 | 120,994.24 | 60.44 | 16.12 | 25.17 | 11.70 | 1,911 | 11,516 | 0.40 |